Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure I: Introduction

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...

Heart Failure III: Clinical Manifestations

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Heart Failure VII: Nursing Interventions

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Heart Failure IV: Classification and Diagnostic Evaluation

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment.

European heart journal. Quality of care & clinical outcomes·2022

Same author

Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidance.

Annales de cardiologie et d'angeiologie·2021

Same author

Gait Speed and Evolution of Verbal Fluencies in Frail or Prefrail Older People with Type 2 Diabetes. A Pilot Study.

The journal of nutrition, health & aging·2021

Same author

Central sleep apnea after acute coronary syndrome and association with ticagrelor use.

Sleep medicine·2021

Same author

The Use of Posturography in Investigating the Risk of Falling in Frail or Prefrail Older People with Diabetes.

The Journal of frailty & aging·2020

Same author

Frailty and Brain-Muscle Correlates in Older People With Type 2 Diabetes: A structural-MRI Explorative Study.

The journal of nutrition, health & aging·2019

Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010

Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010

Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010

Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010

Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010

Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

[Heart failure and cachexia].

J Y Tabet¹, P Meurin, A Ben Driss

¹Centre de réadaption cardiaque des Grands Près 27, rue Sainte-Christine, Villeneuve-Saint-Denis. jtabet@free.fr

Archives Des Maladies Du Coeur Et Des Vaisseaux

|October 24, 2008

Summary

This summary is machine-generated.

Cachexia, a malnutrition state linked to chronic diseases like heart failure, involves significant weight loss and muscle wasting. Current treatments focus on prevention, with limited evidence for hormonal or nutritional therapies.

Related Experiment Videos

Last Updated: Jun 28, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Area of Science:

Biomedical Science
Clinical Medicine
Pathophysiology

Context:

Cachexia is a complex malnutrition syndrome associated with chronic diseases, notably cancer and heart failure.
It is characterized by unintentional weight loss (>7.5% body mass over 6 months), nutritional deficiencies, and metabolic abnormalities leading to fat and lean mass depletion.
Cachexia significantly worsens prognosis in affected patients.

Purpose:

To explore the similarities in pathophysiology between cachexia and heart failure.
To review current therapeutic strategies for cachexia, emphasizing preventive measures.
To identify gaps in evidence regarding hormonal and nutritional interventions.

Summary:

Cachexia involves hypercatabolism, nutritional deficits, and metabolic dysfunction, leading to significant weight and muscle loss.
Shared pathophysiological mechanisms with heart failure include neuro-hormonal activation, cortisol/DHEA imbalance, and pro-inflammatory cytokine activity.
Current management relies on ACE-inhibitors, beta-blockers, and physical reconditioning, with unproven benefits from hormonal and nutritional substitutes.

Impact:

Highlights the complex interplay between chronic disease and malnutrition.
Underscores the need for further research into effective cachexia treatments.
Provides a foundation for developing targeted therapies to improve patient outcomes in cachexia and related chronic conditions.